Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “healthy-volunteers” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 263
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 263 pipeline programs matching "healthy-volunteers" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

263 results for “healthy-volunteers” Back to intelligence hub

Search results

Page 9 of 11
  1. TAK-648

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  2. TAK-648 Tablet

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  3. TAK-653

    NEUROCRINE BIOSCIENCES INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  4. TAK-781

    Takeda

    Healthy Volunteers

    phase 1 small molecule active

    1 trial
  5. TAK-788

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials
  6. TAK-828

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial
  7. TAK-831

    NEUROCRINE BIOSCIENCES INC

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials
  8. TAK-831 Oral Tablet

    NEUROCRINE BIOSCIENCES INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  9. TAK-831 T2

    NEUROCRINE BIOSCIENCES INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  10. TAK-881

    Takeda

    Healthy Volunteers

    phase 1 mab completed

    3 trials
  11. TAK-906

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials
  12. TAK-906 Oral Capsule

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  13. TAK-915

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  14. TAK-915 suspension

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  15. TAK-925

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  16. TAK-935

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  17. TAK-935 Oral Tablet

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  18. TAK-935 Tablets

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  19. TAK-951

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial
  20. TAK-951 Placebo

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  21. TAK-954

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  22. TAK-988

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial
  23. TAK-994

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  24. TAK-994 Oral Tablet

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.